$VERU
Veru Inc

2020 Q3 Form 10-Q Financial Statement

#000086389420000016 Filed on August 13, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2020 Q2 2019 Q2
Revenue $11.75M $10.32M $9.727M
YoY Change 34.59% 6.11% 76.8%
Cost Of Revenue $2.190M $3.803M $3.156M
YoY Change -24.48% 20.49% 30.0%
Gross Profit $9.560M $6.519M $6.571M
YoY Change 63.98% -0.79% 113.75%
Gross Profit Margin 81.36% 63.16% 67.56%
Selling, General & Admin $3.460M $3.475M $3.547M
YoY Change -4.16% -2.02% -11.86%
% of Gross Profit 36.19% 53.31% 53.98%
Research & Development $3.270M $4.436M $4.866M
YoY Change -9.42% -8.83% 28.48%
% of Gross Profit 34.21% 68.05% 74.05%
Depreciation & Amortization $120.0K $120.0K $130.0K
YoY Change 9.09% -7.69% 18.18%
% of Gross Profit 1.26% 1.84% 1.98%
Operating Expenses $6.730M $7.912M $8.413M
YoY Change -7.68% -5.96% 4.66%
Operating Profit $2.830M -$1.393M -$1.842M
YoY Change -293.84% -24.38% -62.9%
Interest Expense -$1.670M $1.170M $1.091M
YoY Change -17.33% 7.19% -20.93%
% of Operating Profit -59.01%
Other Income/Expense, Net -$60.00K -$1.392M -$932.5K
YoY Change -400.0% 49.27% -47.0%
Pretax Income -$12.94M -$2.785M -$2.775M
YoY Change 271.84% 0.37% -58.74%
Income Tax -$1.110M $240.5K -$458.00
% Of Pretax Income
Net Earnings -$11.83M -$3.025M -$2.774M
YoY Change 286.6% 9.06% -65.02%
Net Earnings / Revenue -100.68% -29.31% -28.52%
Basic Earnings Per Share -$0.05
Diluted Earnings Per Share -$169.3K -$0.05 -$44.02K
COMMON SHARES
Basic Shares Outstanding 69.86M 66.73M 62.79M
Diluted Shares Outstanding 66.73M

Balance Sheet

Concept 2020 Q3 2020 Q2 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $13.60M $15.40M $8.000M
YoY Change 115.87% 92.5% 42.86%
Cash & Equivalents $13.59M $15.39M $8.039M
Short-Term Investments
Other Short-Term Assets $1.500M $2.100M $1.200M
YoY Change -16.67% 75.0% 20.0%
Inventory $6.704M $5.200M $3.131M
Prepaid Expenses
Receivables $5.227M $4.200M $4.767M
Other Receivables -$100.0K -$100.0K $0.00
Total Short-Term Assets $27.01M $26.90M $17.14M
YoY Change 60.74% 56.92% 32.89%
LONG-TERM ASSETS
Property, Plant & Equipment $312.7K $315.5K $314.7K
YoY Change -11.14% 0.24% -37.06%
Goodwill $6.900M $6.879M
YoY Change 0.31%
Intangibles $5.752M $19.93M $20.25M
YoY Change -71.48% -1.55%
Long-Term Investments
YoY Change
Other Assets $766.1K $1.562M $684.1K
YoY Change -22.53% 128.35% -94.61%
Total Long-Term Assets $24.53M $38.30M $36.70M
YoY Change -33.38% 4.37% -9.61%
TOTAL ASSETS
Total Short-Term Assets $27.01M $26.90M $17.14M
Total Long-Term Assets $24.53M $38.30M $36.70M
Total Assets $51.54M $65.20M $53.84M
YoY Change -3.89% 21.1% 0.64%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.813M $3.800M $3.135M
YoY Change -9.99% 21.22% -10.43%
Accrued Expenses $4.900M $6.400M $3.900M
YoY Change -10.91% 64.1% 85.71%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $7.000M $7.000M $4.700M
YoY Change 29.63% 48.94% -26.56%
Total Short-Term Liabilities $14.73M $17.37M $11.66M
YoY Change 5.04% 48.95% -8.16%
LONG-TERM LIABILITIES
Long-Term Debt $5.600M $5.400M $6.300M
YoY Change -16.42% -14.29% 31.25%
Other Long-Term Liabilities $22.98K $800.0K $30.00K
YoY Change -90.7% 2566.67% -70.0%
Total Long-Term Liabilities $22.98K $6.200M $30.00K
YoY Change -90.7% 20566.67% -99.39%
TOTAL LIABILITIES
Total Short-Term Liabilities $14.73M $17.37M $11.66M
Total Long-Term Liabilities $22.98K $6.200M $30.00K
Total Liabilities $21.43M $23.90M $19.10M
YoY Change 0.64% 25.1% 8.55%
SHAREHOLDERS EQUITY
Retained Earnings -$89.19M -$67.16M
YoY Change 27.02%
Common Stock $720.5K $670.0K
YoY Change 7.18%
Preferred Stock
YoY Change
Treasury Stock (at cost) $7.807M $7.807M
YoY Change 0.0%
Treasury Stock Shares $2.184M $2.184M $2.184M
Shareholders Equity $30.11M $41.28M $34.74M
YoY Change
Total Liabilities & Shareholders Equity $51.54M $65.20M $53.84M
YoY Change -3.89% 21.1% 0.64%

Cashflow Statement

Concept 2020 Q3 2020 Q2 2019 Q2
OPERATING ACTIVITIES
Net Income -$11.83M -$3.025M -$2.774M
YoY Change 286.6% 9.06% -65.02%
Depreciation, Depletion And Amortization $120.0K $120.0K $130.0K
YoY Change 9.09% -7.69% 18.18%
Cash From Operating Activities -$340.0K $3.340M -$530.0K
YoY Change -64.58% -730.19% -88.35%
INVESTING ACTIVITIES
Capital Expenditures -$40.00K -$20.00K -$70.00K
YoY Change 0.0% -71.43% 40.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$40.00K -$20.00K -$70.00K
YoY Change 0.0% -71.43% 40.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.430M 9.520M 2.740M
YoY Change 90.67% 247.45% 128.33%
NET CHANGE
Cash From Operating Activities -340.0K 3.340M -530.0K
Cash From Investing Activities -40.00K -20.00K -70.00K
Cash From Financing Activities -1.430M 9.520M 2.740M
Net Change In Cash -1.810M 12.84M 2.140M
YoY Change 3.43% 500.0% -162.94%
FREE CASH FLOW
Cash From Operating Activities -$340.0K $3.340M -$530.0K
Capital Expenditures -$40.00K -$20.00K -$70.00K
Free Cash Flow -$300.0K $3.360M -$460.0K
YoY Change -67.39% -830.43% -89.78%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000863894
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Period End Date
DocumentPeriodEndDate
2020-06-30
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
69863681
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
dei Entity Shell Company
EntityShellCompany
false
dei Entity Small Business
EntitySmallBusiness
true
dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value per share
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Trading Symbol
TradingSymbol
VERU
CY2019Q3 us-gaap Accounts Receivable Gross
AccountsReceivableGross
5410165
CY2020Q2 us-gaap Accounts Receivable Gross
AccountsReceivableGross
5038398
CY2019Q3 us-gaap Accounts Receivable Net
AccountsReceivableNet
5021057
CY2020Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
4144351
CY2019Q3 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
306342
CY2020Q2 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
800625
us-gaap Accretion Expense
AccretionExpense
363520
CY2019Q2 us-gaap Accretion Expense
AccretionExpense
147223
us-gaap Accretion Expense
AccretionExpense
928835
CY2020Q2 us-gaap Accretion Expense
AccretionExpense
369138
dei Entity Registrant Name
EntityRegistrantName
VERU INC.
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2020Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3568749
CY2019Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3458866
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
101981
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
34759
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
356172
CY2018Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
36201
CY2019Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
33143
CY2019Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
33143
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
25643
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
3058
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
7500
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
76479
CY2019Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
21909
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
58497
CY2020Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
18385
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3187972
CY2019Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
922144
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2488747
CY2020Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
782169
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
231926
CY2019Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
77000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
237276
CY2020Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
79000
us-gaap Basis Of Accounting
BasisOfAccounting
<div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;font-weight:bold;">Note 1 &#x2013; Basis of Presentation</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">The accompanying unaudited interim condensed consolidated financial statements for Veru Inc. (&#x201C;we,&#x201D; &#x201C;our,&#x201D; &#x201C;us,&#x201D; &#x201C;Veru&#x201D; or the &#x201C;Company&#x201D;) have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (SEC) for reporting of interim financial information. Pursuant to these rules and regulations, certain information and footnote disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP) have been condensed or omitted, although the Company believes that the disclosures made are adequate to make the information not misleading. Accordingly, these statements do not include all the disclosures normally required by U.S. GAAP for annual financial statements and should be read in conjunction with Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations contained in this report and the audited financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended </font><font style="display: inline;">September&nbsp;30, 201</font><font style="display: inline;">9. The accompanying condensed consolidated balance sheet as of </font><font style="display: inline;">September&nbsp;30, 201</font><font style="display: inline;">9 has been derived from our audited financial statements. The unaudited condensed consolidated statements of operations for the three and </font><font style="display: inline;">nine</font><font style="display: inline;"> months ended </font><font style="display: inline;">June&nbsp;30</font><font style="display: inline;">, 2020 and cash flows for the </font><font style="display: inline;">nine</font><font style="display: inline;"> months ended </font><font style="display: inline;">June&nbsp;30</font><font style="display: inline;">, 2020</font><font style="display: inline;"> are not necessarily indicative of the results to be expected for any future period or for the fiscal year ending </font><font style="display: inline;">September&nbsp;30, 20</font><font style="display: inline;">20. </font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">The preparation of our unaudited interim condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">In the opinion of management, the accompanying unaudited interim condensed consolidated financial statements contain all adjustments (consisting of only normally recurring adjustments) necessary to present fairly the financial position and results of operations as of the dates and for the periods presented.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;text-decoration:underline;">Principles of consolidation and nature of operations</font><font style="display: inline;">:&nbsp;&nbsp;Veru Inc. is </font><font style="display: inline;color:#000000;">referred to in these notes collectively with its subsidiaries as &#x201C;we,&#x201D; &#x201C;our,&#x201D; &#x201C;us,&#x201D; &#x201C;Veru&#x201D; or the &#x201C;Company.&#x201D; </font><font style="display: inline;">The consolidated financial statements include the accounts of Veru and its wholly owned subsidiaries, Aspen Park Pharmaceuticals, Inc. (APP) and The Female Health Company Limited, and The Female Health Company Limited&#x2019;s wholly owned subsidiary, The Female Health Company (UK) plc (The Female Health Company Limited and The Female Health Company (UK) plc, collectively, the &#x201C;U.K. subsidiary&#x201D;), and The Female Health Company (UK) plc&#x2019;s wholly owned subsidiary, The Female Health Company (M) SDN.BHD (the &#x201C;Malaysia subsidiary&#x201D;). All significant intercompany transactions and accounts have been eliminated in consolidation. Prior to the completion of the October 31, 2016 acquisition (the &#x201C;APP Acquisition&#x201D;) of APP through the merger of a wholly owned subsidiary of the Company into APP, the Company had been a single product company engaged in marketing, manufacturing and distributing a consumer healthcare product, the FC2 </font><font style="display: inline;">Female Condom/FC2 Internal Condom&#xAE; (FC2)</font><font style="display: inline;">. The completion of the APP Acquisition transitioned the Company into a biopharmaceutical company </font><font style="display: inline;">focused on oncology and urology</font><font style="display: inline;"> with multiple drug products under clinical development. Most of the Company&#x2019;s net revenues during the three and </font><font style="display: inline;">nine</font><font style="display: inline;"> months ended </font><font style="display: inline;">June&nbsp;30</font><font style="display: inline;">, 2020 and 2019 were derived from sales of FC2. </font> </p> <p style="margin:0pt;font-family:Arial Narrow;font-size: 10pt"> <font style="display: inline;font-family:Times New Roman;font-size:10pt;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;text-decoration:underline;">Reclassifications</font><font style="display: inline;">:&nbsp; </font><font style="display: inline;">Certain prior period amounts on the accompanying unaudited interim condensed consolidated financial statements have been reclassified to conform with the current period presentation. </font><font style="display: inline;">These reclassifications had no effect on </font><font style="display: inline;color:#000000;">the results of operations or financial position for any period presented.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;text-decoration:underline;">Leases</font><font style="display: inline;">:&nbsp;&nbsp;Leases are classified as either operating or finance leases at inception. A right-of-use (ROU) asset and corresponding lease liability are established at an amount equal to the present value of fixed lease payments over the lease term at the commencement date. The ROU asset includes any initial direct costs incurred and lease payments made at or before the commencement date and is reduced by lease incentive payments. The Company has elected not to separate the lease and nonlease components for all classes of underlying assets. The Company uses its incremental borrowing rate as the discount rate to determine the present value of the lease payments for leases that do not have a readily determinable implicit discount rate. The incremental borrowing rate is the rate of interest that the Company would be charged to borrow on a collateralized basis over a similar term and amount in a similar economic environment. The Company determines the incremental borrowing rates for its leases by adjusting the risk-free interest rate with a credit risk premium corresponding to the Company&#x2019;s credit rating. </font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">Operating lease costs are recognized for fixed lease payments on a straight-line basis over the term of the lease. Finance lease costs are a combination of the amortization expense for the ROU asset and interest expense for the outstanding lease liability using the applicable discount rate. Variable lease payments are recognized when incurred based on occurrence or usage. Short-term leases with an initial term of 12 months or less are not recorded on the balance sheet; we recognize lease expense for short-term leases on a straight-line basis over the lease term.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;text-decoration:underline;">Government grants</font><font style="display: inline;">:&nbsp;&nbsp;U.S. GAAP for profit-oriented entities does not define government grants nor is there specific guidance applicable to government grants. Under the Company&#x2019;s accounting policy for government grants and consistent with non-authoritative guidance, government grants are recognized as a reduction of the related expense. Government grants are recognized when there is reasonable assurance that the Company has met the requirements of the grant and there is reasonable assurance that the grant will be received. Grants that compensate the Company for expenses incurred are recognized as a reduction of the related expenses in the same period in which the expenses are recognized. The Company has elected to treat forgivable loans from a government as a government grant when it is probable that the Company will meet the terms for forgiveness of the loan.</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Arial Narrow;font-size: 10pt"> <font style="display: inline;font-family:Times New Roman;font-size:10pt;text-decoration:underline;">Other comprehensive loss</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">:&nbsp;&nbsp;Accounting principles generally require that recognized revenue, expenses, gains and losses be included in net loss. Although certain changes in assets and liabilities, such as foreign currency translation adjustments, are reported as a separate component</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;"> of the equity section of the accompanying unaudited condensed consolidated balance sheets, these items, along with net loss, are components of other comprehensive loss. For the three and </font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">nine</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;"> months ended </font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">June&nbsp;30</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">, 2020 and 2019, comprehensive loss is equivalent to the reported net loss.</font><font style="display: inline;font-family:Times New Roman;color:#000000;font-size:10pt;">&nbsp;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;text-decoration:underline;">Recently Issued Accounting Pronouncements</font><font style="display: inline;">:&nbsp; </font><font style="display: inline;">In February 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2016</font><font style="display: inline;">&#8209;02, </font><font style="display: inline;font-style:italic;">Leases (Topic 842)</font><font style="display: inline;">, &nbsp;</font><font style="display: inline;color:#000000;">which requires that lessees recognize an ROU asset and a lease liability for all leases with lease terms greater than twelve months in the balance sheet. ASU 2016-02 distinguishes leases as either a finance lease or an operating lease, which affects how the leases are measured and presented in the statement of operations and statement of cash flows, and requires disclosure of</font><font style="display: inline;"> key information about leasing arrangements. </font><font style="display: inline;color:#000000;">A modified retrospective transition approach is required upon adoption.</font><font style="display: inline;"> &nbsp;I</font><font style="display: inline;color:#000000;">n July 2018, the FASB issued ASU No. 2018</font><font style="display: inline;color:#000000;">&#8209;10, </font><font style="display: inline;font-style:italic;color:#000000;">Codification Improvements to Topic 842, Leases</font><font style="display: inline;color:#000000;"> to clarify the implementation guidance and ASU No. 2018</font><font style="display: inline;color:#000000;">&#8209;11, </font><font style="display: inline;font-style:italic;color:#000000;">Leases (Topic 842) Targeted Improvements</font><font style="display: inline;color:#000000;">. This updated guidance provides an optional transition method, which allows for the initial application of the new accounting standard at the adoption date and the recognition of a cumulative-effect adjustment to the opening balance of retained earnings as of the beginning of the period of adoption. </font><font style="display: inline;">I</font><font style="display: inline;color:#000000;">n December 2018, the FASB issued ASU 2018-20, </font><font style="display: inline;font-style:italic;color:#000000;">Leases (Topic 842): Narrow-Scope Improvements for Lessors</font><font style="display: inline;color:#000000;"> to address certain implementation issues facing lessors when adopting ASU 2016</font><font style="display: inline;color:#000000;">&#8209;02. </font><font style="display: inline;">I</font><font style="display: inline;color:#000000;">n March 2019, the FASB issued ASU 2019</font><font style="display: inline;color:#000000;">&#8209;01, </font><font style="display: inline;font-style:italic;color:#000000;">Leases (Topic 842): Codification Improvements</font><font style="display: inline;color:#000000;"> to address, among other things, certain transition disclosure requirements subsequent to the adoption of ASU 2016</font><font style="display: inline;color:#000000;">&#8209;02. </font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font> </p> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">The Company adopted the new lease accounting standard using the modified retrospective approach </font><font style="display: inline;">on October&nbsp;1, 2019 and elected certain </font><font style="display: inline;color:#000000;">practical expedients, including the optional transition method that allows for the application of the new standard at its adoption date with no restatement of prior period amounts</font><font style="display: inline;">. We elected the package of practical expedients permitted under the transition guidance, which allowed us to not reassess our prior conclusions about lease identification, lease classification, and initial direct costs. </font><font style="display: inline;color:#000000;">Adoption of the new standard resulted in the recording of ROU assets and lease liabilities of approximately </font><font style="display: inline;color:#000000;">$1.2</font><font style="display: inline;color:#000000;"> million and </font><font style="display: inline;color:#000000;">$1.5</font><font style="display: inline;color:#000000;"> million, respectively, and the derecognition of prepaid expenses and operating lease deferred rent liabilities of </font><font style="display: inline;color:#000000;">$23,000</font><font style="display: inline;color:#000000;"> and </font><font style="display: inline;color:#000000;">$247,000</font><font style="display: inline;color:#000000;">, respectively, as of October 1, 2019 with </font><font style="display: inline;color:#000000;">zero</font><font style="display: inline;color:#000000;"> cumulative-effect adjustment to retained earnings. The new standard did not materially impact our consolidated statement of operations or cash flows</font><font style="display: inline;">.</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">In June 2018, the FASB issued ASU 2018</font><font style="display: inline;color:#000000;">&#8209;07,&nbsp;</font><font style="display: inline;font-style:italic;color:#000000;">Compensation - Stock Compensation&nbsp;</font><font style="display: inline;font-style:italic;color:#000000;">(Topic 718)</font><font style="display: inline;font-style:italic;color:#000000;">: Improvements to Nonemployee Share-Based Payment Accounting</font><font style="display: inline;color:#000000;">. The purpose of ASU 2018-07 is to expand the scope of </font><font style="display: inline;font-style:italic;color:#000000;">Topic 718, Compensation&#x2014;Stock Compensation</font><font style="display: inline;color:#000000;"> (which </font><font style="display: inline;color:#000000;">previousl</font><font style="display: inline;color:#000000;">y only include</font><font style="display: inline;color:#000000;">d</font><font style="display: inline;color:#000000;"> share-based payments to employees) to include share-based payments issued to nonemployees for goods or services. Consequently, the accounting for share-based payments to nonemployees and employees will be substantially aligned. The Company has issued share-based payments to nonemployees in the past but is not able to predict the amount of future share-based payments to nonemployees, if any. We adopted ASU 2018-07 effective October 1, 2019. The adoption of ASU 2018</font><font style="display: inline;color:#000000;">&#8209;07 did not have a material impact on our consolidated financial statements and related disclosures.</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">&#xFEFF;</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;color:#000000;">In December 2019, the FASB issued ASU 2019-12, </font><font style="display: inline;font-style:italic;color:#000000;">Income Taxes (Topic 740). Simplifying the Accounting for Income Taxes</font><font style="display: inline;color:#000000;">. The new guidance eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. It also clarifies and simplifies other aspects of the accounting for income taxes. ASU 2019-12 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early adoption is permitted. The adoption of ASU 2019-12 is not expected to have a material effect on our consolidated financial statements and related disclosures.</font> </p> <p style="margin:0pt;line-height:normal;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;">&nbsp;</font> </p> <p><font size="1"> </font></p> </div> </div>
CY2019Q3 us-gaap Capital Leased Assets Gross
CapitalLeasedAssetsGross
43000
CY2019Q3 us-gaap Capital Lease Obligations
CapitalLeaseObligations
42000
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3759509
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8039116
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
15394423
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4279607
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
9099271
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6295152
CY2020Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
12834095
CY2019Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
154000000
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
154000000
CY2019Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
67221951
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
72047385
CY2019Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
65038247
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
69863681
CY2019Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
249000
CY2020Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
249000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
723000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7250895
CY2019Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3155902
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9618163
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3802636
CY2019Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
8433669
CY2020Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
8628006
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
20413
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-198202
CY2019Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
296605
CY2020Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
292740
CY2019Q3 us-gaap Deferred Revenue
DeferredRevenue
0
CY2020Q2 us-gaap Deferred Revenue
DeferredRevenue
0
CY2020Q2 us-gaap Deferred Tax Asset Interest Carryforward
DeferredTaxAssetInterestCarryforward
757141
CY2020Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
23762204
CY2020Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
8854855
CY2019Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
10486476
CY2020Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
10600648
CY2020Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
1686902
CY2019Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
804378
CY2020Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1116240
CY2020Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
10928109
CY2020Q2 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
53872
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.14
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.11
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2019Q2 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
246000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
94000
CY2018Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
2426000
CY2019Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
2672000
CY2019Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
3625000
CY2020Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
3719000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
4097
CY2020Q2 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
1238
CY2020Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
32866
CY2020Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
20000
CY2020Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
12000
CY2020Q2 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
37127
CY2020Q2 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
9496
CY2020Q2 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
22199
CY2020Q2 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
5432
CY2020Q2 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
4261
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
9444
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
6535
CY2020Q2 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
2178
CY2020Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.1386
CY2019Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
731505
CY2020Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
968781
CY2019Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2900000
CY2020Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2900000
CY2019Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2168495
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1931219
us-gaap Gain Loss On Derivative Instruments Held For Trading Purposes Net
GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet
-246000
CY2019Q2 us-gaap Gain Loss On Derivative Instruments Held For Trading Purposes Net
GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet
157000
us-gaap Gain Loss On Derivative Instruments Held For Trading Purposes Net
GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet
-94000
CY2020Q2 us-gaap Gain Loss On Derivative Instruments Held For Trading Purposes Net
GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet
-169000
us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0
us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0
us-gaap Gross Profit
GrossProfit
15824089
CY2019Q2 us-gaap Gross Profit
GrossProfit
6571158
us-gaap Gross Profit
GrossProfit
21224711
CY2020Q2 us-gaap Gross Profit
GrossProfit
6519118
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8839702
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2774534
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7110371
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2784878
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
117207
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-458
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
30619
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
240502
CY2019Q2 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
716442
CY2020Q2 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
415449
CY2019Q2 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
43
CY2020Q2 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-16478
CY2020Q2 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-584825
us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
7052
CY2020Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P1Y8M12D
us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1097900
us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
2367633
us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
49908
us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1856337
CY2019Q2 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-582652
us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1493179
us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-23887
us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
54094
us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-439952
CY2019Q2 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-138089
us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-115615
us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-3484
CY2019Q2 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
2269
us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
335869
CY2020Q2 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
332230
CY2019Q2 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-1025
CY2020Q2 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
53872
CY2020Q2 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-45268
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-46894
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
648239
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
791272
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-194471
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
566557
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
556330
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-187159
us-gaap Increase Decrease In Derivative Assets And Liabilities
IncreaseDecreaseInDerivativeAssetsAndLiabilities
-246000
us-gaap Increase Decrease In Derivative Assets And Liabilities
IncreaseDecreaseInDerivativeAssetsAndLiabilities
-94000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
941188
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1775018
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
68578
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4794
CY2019Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
20900000
CY2020Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
20900000
CY2019Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
20168495
CY2020Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
19931219
us-gaap Interest Expense
InterestExpense
3627971
CY2019Q2 us-gaap Interest Expense
InterestExpense
1091276
us-gaap Interest Expense
InterestExpense
3476079
CY2020Q2 us-gaap Interest Expense
InterestExpense
1169692
us-gaap Inventory Write Down
InventoryWriteDown
112498
us-gaap Inventory Write Down
InventoryWriteDown
227982
us-gaap Lease Cost
LeaseCost
350505
CY2020Q2 us-gaap Lease Cost
LeaseCost
108436
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1562059
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
164725
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
191559
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
295258
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
350054
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
431061
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
17372912
CY2019Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1436888
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1562126
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
129402
CY2020Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
328522
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
425136
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
808401
CY2020Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.1202
us-gaap Operating Lease Payments
OperatingLeasePayments
350000
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1012951
CY2019Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
1365940
CY2019Q3 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
469002
CY2019Q3 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
11238
CY2019Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
114493
CY2019Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
337456
CY2019Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
433751
CY2019Q3 us-gaap Operating Leases Future Minimum Payments Receivable
OperatingLeasesFutureMinimumPaymentsReceivable
786754
CY2019Q3 us-gaap Operating Leases Future Minimum Payments Receivable Current
OperatingLeasesFutureMinimumPaymentsReceivableCurrent
198668
CY2019Q3 us-gaap Liabilities
Liabilities
21295634
CY2019Q3 us-gaap Liabilities Current
LiabilitiesCurrent
14019975
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8884760
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10761699
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-74948
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-73444
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4530205
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1588984
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
-2148798
us-gaap Net Income Loss
NetIncomeLoss
-8956909
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-4034035
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-2774076
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
-3305101
us-gaap Net Income Loss
NetIncomeLoss
-7140990
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-810509
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-3025380
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3861383
CY2019Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-932532
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3633448
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1392026
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
us-gaap Operating Expenses
OperatingExpenses
20802408
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
8413160
us-gaap Operating Expenses
OperatingExpenses
24701634
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
7911970
us-gaap Operating Income Loss
OperatingIncomeLoss
-4978319
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1842002
us-gaap Operating Income Loss
OperatingIncomeLoss
-3476923
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1392852
us-gaap Operating Lease Cost
OperatingLeaseCost
378006
CY2020Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
124326
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
1233537
CY2019Q3 us-gaap Operating Leases Future Minimum Payments Receivable In Three Years
OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears
190749
CY2019Q3 us-gaap Operating Leases Future Minimum Payments Receivable In Two Years
OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears
203584
CY2019Q3 us-gaap Operating Leases Future Minimum Payments Receivable Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsReceivableRemainderOfFiscalYear
193753
CY2020Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y
CY2020Q2 veru Accrued Research And Development Costs Current
AccruedResearchAndDevelopmentCostsCurrent
2277491
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2125730
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-3627971
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-3476079
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
12588
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1744
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-63369
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-53334
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
148674
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
7500
us-gaap Other Significant Noncash Transaction Value Of Consideration Given1
OtherSignificantNoncashTransactionValueOfConsiderationGiven1
680937
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
268033
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
74948
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
73444
CY2019Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1843297
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div> <div style="margin-left:0pt;margin-right:0pt;"> <p style="margin:0pt;font-family:Times New Roman;font-size: 10pt"> <font style="display: inline;text-decoration:underline;">Reclassifications</font><font style="display: inline;">:&nbsp; </font><font style="display: inline;">Certain prior period amounts on the accompanying unaudited interim condensed consolidated financial statements have been reclassified to conform with the current period presentation. </font><font style="display: inline;">These reclassifications had no effect on </font><font style="display: inline;color:#000000;">the results of operations or financial position for any period presented.</font> </p> <p><font size="1"> </font></p> </div> </div>
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
9400000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3600000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
13399999
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
836780
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
200000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
415000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
415464
CY2019Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3810761
CY2020Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3884205
CY2019Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
351895
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
315456
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
4047207
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
3325180
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
555920
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10138524
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4866114
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13666730
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4436496
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23074984
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9727060
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
30842874
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10321754
us-gaap Revenues
Revenues
23074984
CY2019Q2 us-gaap Revenues
Revenues
9727060
us-gaap Revenues
Revenues
30842874
CY2020Q2 us-gaap Revenues
Revenues
10321754
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1253233
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
10663884
CY2019Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3547046
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11034904
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3475474
us-gaap Share Based Compensation
ShareBasedCompensation
1381672
us-gaap Share Based Compensation
ShareBasedCompensation
1981492
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
us-gaap Short Term Lease Cost
ShortTermLeaseCost
5589
CY2020Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
1863
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
29481418
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
36881843
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
33544017
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
34736167
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
32333136
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
29642533
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
31114577
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
41279107
CY2020Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
680937
CY2018Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
9131967
CY2019Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3600000
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1227000
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
12172999
CY2018Q4 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
417256
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
496209
CY2019Q2 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
468207
CY2019Q4 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
614498
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
681680
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
685314
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
200000
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
408632
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6832
us-gaap Sublease Income
SubleaseIncome
135071
CY2020Q2 us-gaap Sublease Income
SubleaseIncome
45382
CY2019Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
2183704
CY2020Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
2183704
us-gaap Variable Lease Cost
VariableLeaseCost
91349
CY2020Q2 us-gaap Variable Lease Cost
VariableLeaseCost
24213
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
62745355
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
62917362
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
65709139
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
66728782
CY2019Q3 veru Allowance For Sales And Payment Term Discounts
AllowanceForSalesAndPaymentTermDiscounts
49623
CY2020Q2 veru Allowance For Sales And Payment Term Discounts
AllowanceForSalesAndPaymentTermDiscounts
67779
veru Amortization Of Deferred Costs Related To Stock Issuance
AmortizationOfDeferredCostsRelatedToStockIssuance
101981
veru Amortization Of Deferred Costs Related To Stock Issuance
AmortizationOfDeferredCostsRelatedToStockIssuance
390931
CY2019Q3 veru Deferred Tax Assets Foreign Capital Allowance
DeferredTaxAssetsForeignCapitalAllowance
103400
CY2020Q2 veru Deferred Tax Assets Foreign Capital Allowance
DeferredTaxAssetsForeignCapitalAllowance
103400
CY2019Q3 veru Deferred Tax Liabilities Developed Technology
DeferredTaxLiabilitiesDevelopedTechnology
424657
CY2020Q2 veru Deferred Tax Liabilities Developed Technology
DeferredTaxLiabilitiesDevelopedTechnology
383092
CY2020Q2 veru Deferred Tax Liabilities In Process R And D
DeferredTaxLiabilitiesInProcessRAndD
4072740
veru Depreciation And Other Amortization
DepreciationAndOtherAmortization
126084
veru Depreciation And Other Amortization
DepreciationAndOtherAmortization
109883
CY2020Q2 veru Proceeds From Ppp Loan Cares Act
ProceedsFromPppLoanCaresAct
540000
veru Income Tax Reconciliation Effect Of Global Intangible Low Taxed Income
IncomeTaxReconciliationEffectOfGlobalIntangibleLowTaxedIncome
66182
veru Income Tax Reconciliation Effect Of Global Intangible Low Taxed Income
IncomeTaxReconciliationEffectOfGlobalIntangibleLowTaxedIncome
101642
CY2019Q3 veru Deferred Tax Liabilities In Process R And D
DeferredTaxLiabilitiesInProcessRAndD
4072740
veru Noncash Or Part Noncash Transaction Change In Other Assets From Accrued Expenses
NoncashOrPartNoncashTransactionChangeInOtherAssetsFromAccruedExpenses
50284
veru Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-243514
CY2019Q2 veru Income Tax Reconciliation Effect Of Global Intangible Low Taxed Income
IncomeTaxReconciliationEffectOfGlobalIntangibleLowTaxedIncome
2554
CY2020Q2 veru Income Tax Reconciliation Effect Of Global Intangible Low Taxed Income
IncomeTaxReconciliationEffectOfGlobalIntangibleLowTaxedIncome
85522
CY2020Q2 veru Lessee Sublease Future Minimum Payments Due
LesseeSubleaseFutureMinimumPaymentsDue
641746
CY2020Q2 veru Lessee Sublease Future Minimum Payments Due Remainder Of Fiscal Year
LesseeSubleaseFutureMinimumPaymentsDueRemainderOfFiscalYear
48745
CY2020Q2 veru Lessee Sublease Future Minimum Payments Due Year Four
LesseeSubleaseFutureMinimumPaymentsDueYearFour
190749
CY2020Q2 veru Lessee Sublease Future Minimum Payments Due Year Three
LesseeSubleaseFutureMinimumPaymentsDueYearThree
203584
CY2020Q2 veru Lessee Sublease Future Minimum Payments Due Year Two
LesseeSubleaseFutureMinimumPaymentsDueYearTwo
198668
veru Operating Lease Right Of Use Assets Non Cash Change
OperatingLeaseRightOfUseAssetsNonCashChange
240282
CY2019Q3 veru Operating Leases Future Minimum Payments Due Net Of Sublease Income
OperatingLeasesFutureMinimumPaymentsDueNetOfSubleaseIncome
579186
CY2019Q3 veru Operating Leases Future Minimum Payments Due Net Of Sublease Income Current
OperatingLeasesFutureMinimumPaymentsDueNetOfSubleaseIncomeCurrent
275249
CY2019Q3 veru Operating Leases Future Minimum Payments Due Net Of Sublease Income Year Five
OperatingLeasesFutureMinimumPaymentsDueNetOfSubleaseIncomeYearFive
11238
CY2019Q3 veru Operating Leases Future Minimum Payments Due Net Of Sublease Income Year Four
OperatingLeasesFutureMinimumPaymentsDueNetOfSubleaseIncomeYearFour
-76256
CY2019Q3 veru Operating Leases Future Minimum Payments Due Net Of Sublease Income Year Three
OperatingLeasesFutureMinimumPaymentsDueNetOfSubleaseIncomeYearThree
133872
CY2019Q3 veru Operating Leases Future Minimum Payments Due Net Of Sublease Income Year Two
OperatingLeasesFutureMinimumPaymentsDueNetOfSubleaseIncomeYearTwo
235083
veru Ppp Loan Interest Rate
PppLoanInterestRate
0.01
veru Ppp Loan Maturity Period
PppLoanMaturityPeriod
P2Y
CY2020Q2 veru Product Liability Insurance Coverage Amount
ProductLiabilityInsuranceCoverageAmount
10000000
veru Reduction Of Research And Development Expense Cares Act
ReductionOfResearchAndDevelopmentExpenseCaresAct
120000
CY2020Q2 veru Reduction Of Research And Development Expense Cares Act
ReductionOfResearchAndDevelopmentExpenseCaresAct
120000
veru Reduction Of Selling General And Administrative Expense Cares Act
ReductionOfSellingGeneralAndAdministrativeExpenseCaresAct
420000
CY2020Q2 veru Reduction Of Selling General And Administrative Expense Cares Act
ReductionOfSellingGeneralAndAdministrativeExpenseCaresAct
420000
CY2020Q2 veru Residual Royalty Agreement Current
ResidualRoyaltyAgreementCurrent
356346
CY2019Q3 veru Residual Royalty Agreement Noncurrent
ResidualRoyaltyAgreementNoncurrent
3845518

Files In Submission

Name View Source Status
R10.htm Edgar Link pending
0000863894-20-000016-index-headers.html Edgar Link pending
0000863894-20-000016-index.html Edgar Link pending
0000863894-20-000016.txt Edgar Link pending
0000863894-20-000016-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
veru-20200630.xml Edgar Link completed
veru-20200630.xsd Edgar Link pending
veru-20200630x10q.htm Edgar Link pending
veru-20200630xex31_1.htm Edgar Link pending
veru-20200630xex31_2.htm Edgar Link pending
veru-20200630xex32_1.htm Edgar Link pending
veru-20200630_cal.xml Edgar Link unprocessable
veru-20200630_def.xml Edgar Link unprocessable
veru-20200630_lab.xml Edgar Link unprocessable
veru-20200630_pre.xml Edgar Link unprocessable